Purchases and Sales Made in Q2 2023 in Akari Therapeutics PLC (AKTX)
This table provides information about the institutional ownership of Akari Therapeutics PLC (AKTX) during Q2 2023. The information is specifically focused on institutions that hold shares of Akari Therapeutics Plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Cerity Partners LLC
New York, NY |
BUY
|
- |
323KNew |
$51.7K - $71K
|
323K
$323K
|
|
Aug 14, 2023
Q2 2023
|
Cresset Asset Management, LLC
Chicago, IL |
BUY
|
- |
217KNew |
$34.7K - $47.7K
|
217K
$217K
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
34.7K+ 12.24% |
$5.55K - $7.63K
|
318K
$318K
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
24.5KNew |
$3.91K - $5.38K
|
24.5K
$24.5K
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.6KNew |
$2.82K - $3.87K
|
17.6K
$17.6K
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
16.4KNew |
$2.63K - $3.62K
|
16.4K
$16.4K
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-127K- 48.68% |
$20.3K - $28K
|
134K
$134K
|
|
Aug 14, 2023
Q2 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-550K- 6.92% |
$88K - $121K
|
7.39M
$7.39M
|